CFG
FLGT icon

CKW Financial Group’s Fulgent Genetics FLGT Stock Holding History

CKW Financial Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-218
Closed -$7K – 205
2023
Q1 		$7K Hold
218
– – ﹤0.01% 166
2022
Q4 		$6K Hold
218
– – ﹤0.01% 170
2022
Q3 		$8K Hold
218
– – ﹤0.01% 167
2022
Q2 		$12K Hold
218
– – ﹤0.01% 160
2022
Q1 		$14K Hold
218
– – ﹤0.01% 157
2021
Q4 		$20K Hold
218
– – ﹤0.01% 155
2021
Q3 		$18K Hold
218
– – ﹤0.01% 168
2021
Q2 		$19K Buy
218
+18
+9% +$1.44K ﹤0.01% 175
2021
Q1 		$19K Buy
+200
New +$20.6K ﹤0.01% 144

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

CKW Financial Group's FLGT Position: Q2 2023 in Review

CKW Financial Group sold out of Fulgent Genetics (FLGT) in Q2 2023, closing a stake of 218 shares — an estimated $7K sold.

CKW Financial Group first reported a position in FLGT in Q1 2021 and held it in 9 quarters. The position peaked at $20K in Q4 2021. 214 funds tracked by Wall St. Rank hold FLGT as of Q2 2023.

  • CKW Financial Group reported no remaining Fulgent Genetics position as of Q2 2023 after selling out during the quarter.
  • CKW Financial Group sold 218 Fulgent Genetics shares in Q2 2023, an estimated $7K.
  • CKW Financial Group first reported a position in Fulgent Genetics in Q1 2021 and held it in 9 quarters.
  • CKW Financial Group's Fulgent Genetics position peaked at $20K in Q4 2021.
  • 214 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2023.

Based on CKW Financial Group's 13F filing for Q2 2023, filed 18 Jul 2023.